J. Angulo et al., IMPAIRMENT OF NITRIC OXIDE-MEDIATED RELAXATIONS IN ANESTHETIZED AUTOPERFUSED STREPTOZOTOCIN-INDUCED DIABETIC RATS, Naunyn-Schmiedeberg's archives of pharmacology, 358(5), 1998, pp. 529-537
This work was designed to determine in vivo the influence of the metab
olic control of streptozotocin-induced diabetic rats, measured by the
levels of haemoglobin glycosylation in blood (HbA(lc)), on developing
vascular endothelial dysfunction. For this, the vasoactive responses t
o basal and stimulated endothelial nitric oxide (NO) were studied usin
g the technique of the anaesthetized autoperfused rat, analyzing the r
esponses to acetylcholine (ACh) and N-G-nitro-L-arginine methyl ester
(L-NAME) in non-diabetic and diabetic rats with different degrees of m
etabolic control (four groups with HbA(lc) levels of 5.5-7.4%, 7.5-9.4
%, 9.5-12%, and >12%, respectively). When administered over a noradren
aline-induced vasopressor tone, ACh (0.25, 0.75, 2.5, 7.5 and 25 mu g
kg(-1)) induced dose-dependent vasodilatatory responses in all rat gro
ups, reducing both mean arterial pressure and perfusion pressure of th
e left hindlimb. These responses were similar in non-diabetic and in d
iabetic rats with good metabolic control (HbA(lc) 5.5-7.4%), while dia
betic rats with levels of HbA(lc) higher than 7.5% showed significantl
y lower vasodilatatory responses to ACh. In untreated diabetic rats, t
he relaxant responses evoked by the NO donor sodium nitroprusside were
also impaired. On the other hand, increasing doses of L-NAME (0.1 to
10 mg kg(-1)) enhanced both mean arterial pressure and left hindlimb p
erfusion pressure in diabetic and non-diabetic rats. As with ACh, the
responses to L-NAME were significantly reduced in diabetic rats with H
bA(lc) levels higher than 7.5%. To determine the mechanism underlying
the NO-mediated endothelial dysfunction, the responses to ACh in untre
ated diabetic rats (HbA(lc) >12%) were studied in the presence of the
NO substrate L-arginine, in the presence of the oxygen-derived free ra
dical scavenger superoxide dismutase (SOD), or in the presence of both
compounds. Both L-arginine and SOD produced a partial improvement of
the ACh-induced vasodilatatory responses, but the effects of these age
nts were not additive. In this group of animals, SOD also induced a pa
rtial recovery of the L-NAME-evoked vasoconstrictions. In non-diabetic
and untreated diabetic rats, the plasma levels of NO derivatives and
arginine were measured. No significant differences were obtained in th
e amount of nitrites plus nitrates, while plasma levels of arginine we
re markedly reduced in the untreated diabetic animals. The results ind
icate that the endothelial dysfunction associated to diabetes is close
ly related to the level of metabolic control of the disease. Therefore
, it is possible to establish a threshold for developing endothelium i
mpairment from percentages of HbA(lc) higher than 7.5%. As the respons
es to the NO synthase blocker L-NAME were analogously impaired, it is
reasonable to suggest that diabetic endothelial dysfunction is related
to the interference with mechanisms linked both to stimulated and bas
al production of NO. We suggest that this interference is partially du
e to a deficit in the substrate availability for NO and to an increase
d generation of superoxide anions.